Cosmos Health (NASDAQ:COSM) stated on Friday that it prolonged and up to date its settlement to amass ZipDoctor from American International Holdings (OTCQB:AMIH).
Cosmos famous that it efficiently renegotiated the acquisition value of ZipDoctor to attain improved cost terms.
The up to date letter of intent will stay efficient till Feb. 15, in accordance with the corporate.
Drug distributor Cosmos had signed a non-binding letter of intent to amass subscription-based telemedicine platform ZipDoctor, a unit of AMIH, in September 2022.
“Furthermore, we intend to increase on ZipDoctor’s present major care and psychological well being service choices to incorporate the flexibility to talk to a physician to hunt extra medical remedies associated to and together with males’s and girls’s well being and wellness points, weight reduction and different comparable remedies. Furthermore, we’re happy with the renegotiated value of the acquisition, as we’re at all times seeking to improve our returns on funding,” stated Cosmos CEO Greg Siokas.
In addition, Cosmos supplied an replace on its ongoing review of COSM trading patterns.
The firm stated that it lately acquired trading exercise knowledge from Shareholder Intelligence Services and the administration was reviewing the info to develop its subsequent plan of action.
COSM -11.63% to $4.71 premarket Jan. 23